Insider · CIK 0001835458

Ragosa Mark

Reports to the SEC for 1 company · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001835458

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,694 sh	—	—	18,848
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,750 sh	—	—	20,598
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,591 sh	—	—	22,189
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+3,069 sh	—	—	25,258
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−4,404 sh	$79.28	−$349K	20,854
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+7,800 sh	—	—	7,800
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	CHIEF FINANCIAL OFFICER	AAward	+31.2K sh	—	—	31,150
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−3,069 sh	—	—	9,206
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,591 sh	—	—	3,182
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,750 sh	—	—	1,750
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−2,694 sh	—	—	0
2026-04-07	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,694 sh	—	—	17,457
2026-04-07	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−1,303 sh	$48.94	−$63.8K	16,154
2026-04-07	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−2,694 sh	—	—	0
2026-04-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+5,187 sh	—	—	17,273
2026-04-01	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−2,510 sh	$48.13	−$121K	14,763
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	CHIEF FINANCIAL OFFICER	AAward	+31.2K sh	—	—	31,150
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+7,800 sh	—	—	7,800
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Performance Share UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+15.6K sh	—	—	15,600
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,750 sh	—	—	1,750
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,591 sh	—	—	3,182
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,846 sh	—	—	5,536
2026-03-09	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,036 sh	$22.89	+$46.6K	14,122
2026-03-09	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+10.5K sh	$17.76	+$187K	24,635
2026-03-09	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+13.8K sh	$18.06	+$249K	38,448
2026-03-09	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+10.4K sh	$26.74	+$277K	48,808
2026-03-09	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF FINANCIAL OFFICER	SSale	−18K sh	$45.58	−$820K	30,827
2026-03-09	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF FINANCIAL OFFICER	SSale	−18.7K sh	$46.24	−$867K	12,086
2026-03-09	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−2,036 sh	—	—	0
2026-03-09	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−10.5K sh	—	—	18,396
2026-03-09	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−13.8K sh	—	—	19,337
2026-03-09	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−10.4K sh	—	—	22,790
2026-02-09	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+8,374 sh	$12.97	+$109K	27,460
2026-02-09	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,471 sh	$16.90	+$41.8K	29,931
2026-02-09	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF FINANCIAL OFFICER	SSale	−9,114 sh	$42.85	−$391K	20,817
2026-02-09	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF FINANCIAL OFFICER	SSale	−8,731 sh	$43.72	−$382K	12,086
2026-02-09	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−8,374 sh	—	—	0
2026-02-09	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−2,471 sh	—	—	0
2026-01-08	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF FINANCIAL OFFICER	SSale	−12K sh	$41.89	−$503K	19,086
2025-12-08	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+16.2K sh	$11.10	+$179K	47,250
2025-12-08	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+16.2K sh	$11.97	+$193K	63,415
2025-12-08	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+10.5K sh	$10.76	+$113K	73,927
2025-12-08	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF FINANCIAL OFFICER	SSale	−42.8K sh	$41.49	−$1.78M	31,086
2025-12-08	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−16.2K sh	—	—	5,388
2025-12-08	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−16.2K sh	—	—	12,123
2025-12-08	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−10.5K sh	—	—	14,016
2025-11-12	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+19.9K sh	$30.93	+$616K	50,986
2025-11-12	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF FINANCIAL OFFICER	SSale	−19.9K sh	$40.94	−$815K	31,086
2025-11-12	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−19.9K sh	—	—	0
2025-10-28	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+100 sh	$30.93	+$3,093	31,186

Recent filings

Accepted (ET)
Sep 34
Ragosa Mark0001835458-26-000012
SEC(opens sec.gov)
Apr 84
Ragosa Mark0001835458-26-000010
SEC(opens sec.gov)
Apr 34
Ragosa Mark0001835458-26-000008
SEC(opens sec.gov)

Companies

Kiniksa Pharmaceuticals International, plcCHIEF FINANCIAL OFFICERKNSA

Address

C/O KINIKSA PHARMACEUTICALS INT'L 105 PICCADILLY, SECOND FLOOR

LONDON, W1J 7NJ